Topical Nitro or Placebo Pre-Cath

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 256 participants.

Also called NCT06289946

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 256 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06289946
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06289946. Randomized; double masking; primary purpose treatment. Start 2024-03-01 (anticipated); primary completion 2025-03-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Topical Nitro or Placebo Pre-Cath
Intervention (Drug)
NitroBid
Intervention (Drug)
Placebo
Lead sponsor
Thomas Jefferson University (class: other)

Record details

Record id
cardio:ct-nct06289946
Content hash
7ad0406841a44085230711208f2288065f680441f1d55399b7d310787dd3c888